Saar I. Gill, MD, PhD

Novel approaches to enhancing the therapeutic index of chimeric antigen receptor T cell therapy for acute myeloid leukemia

The aim of this project is to develop a technology that will allow a powerful immune cell attack against leukemia without damaging normal bone marrow cells, thereby increasing the safety of cancer immunotherapy.